文献速递糖尿病

连续血糖监测对2型糖尿病血糖控制指标的有效性:随机对照试验的系统综述与Meta分析

Effectiveness of Continuous Glucose Monitoring on Metrics of Glycemic Control in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
PubMed 文献 · J Clin Endocrinol Metab · 2024-01-01

该系统综述与Meta分析纳入14项随机对照试验,评估实时连续血糖监测(rt-CGM)或扫描式连续血糖监测(FGM)对成人2型糖尿病患者血糖控制的影响,其中9项试验825例使用rt-CGM,5项试验822例使用FGM。中等确定性证据表明,使用连续血糖监测可使HbA1c适度但统计学显著降低约0.32%;分设备类型分析显示rt-CGM和FGM的HbA1c降低幅度相似(分别为0.34%和0.33%),其他血糖指标有改善趋势且倾向于rt-CGM优于自我血糖监测。结论认为两者均能适度降低HbA1c且异质性小,但纳入试验持续时间较短,报告重要临床结局的研究较少,需要更长期研究。

要点

  • 连续血糖监测使2型糖尿病患者HbA1c适度但统计学显著降低约0.32%(中等确定性证据)。
  • rt-CGM与FGM分别降低HbA1c 0.34%和0.33%,其他血糖指标有改善趋势且倾向rt-CGM优于自我血糖监测。
  • 纳入随机对照试验持续时间较短,报告不良事件、急诊就诊或住院等重要临床结局的研究较少。

核心结论

  • rt-CGM和FGM均可使2型糖尿病患者的HbA1c适度但统计学显著下降,结果异质性小。
  • 由于纳入随机对照试验持续时间较短且报告重要临床结局的研究较少,需要更长期研究来确定短期血糖控制改善是否带来临床重要结局的改善。

研究设计与样本

  • 系统综述与Meta分析,检索MEDLINE、Embase和Cochrane数据库,纳入评估rt-CGM或FGM在成人(≥18岁)2型糖尿病患者中效果的随机对照试验。
  • 共纳入14项随机对照试验,其中9项试验825例患者使用rt-CGM,5项试验822例患者使用FGM。
  • 采用GRADE方法评估主要结局的证据确定性。

主要发现

  • 中等确定性证据表明,使用连续血糖监测使HbA1c适度但统计学显著降低约0.32%。
  • 分设备类型分析显示,rt-CGM和FGM的HbA1c降低幅度相似,分别为0.34%和0.33%。
  • 其他血糖指标有改善趋势,且倾向于rt-CGM优于自我血糖监测。
  • 结果异质性小。

关键数值与推荐

  • 纳入的随机对照试验需报告以下至少1项结局:HbA1c、目标范围内时间、高血糖时间或低血糖时间。
  • 连续血糖监测使HbA1c降低约0.32%(中等确定性证据)。
  • rt-CGM使HbA1c降低0.34%,FGM使HbA1c降低0.33%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 纳入的随机对照试验持续时间相对较短。
  • 报告重要临床结局(如不良事件、急诊就诊或住院)的研究较少。
  • 需要更长期研究来确定短期血糖控制改善是否带来临床重要结局的改善。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To provide a systematic review and meta-analysis synthesizing the findings of randomized controlled trials (RCTs) of continuous glucose monitors (CGMs) in the management of adults with type 2 diabetes mellitus (T2DM) on glucose control and clinical outcomes. METHODS: MEDLINE, Embase, and Cochrane were searched for RCTs that assessed the effectiveness of real-time CGM (rt-CGM) or flash CGM (FGM) in adults (≥18 years) with T2DM that reported on at least 1 of the following outcomes: hemoglobin A1c (HbA1c), time in range, time in hyperglycemia, or time in hypoglycemia. The GRADE approach was used to assess certainty of evidence for primary outcomes. RESULTS: Fourteen RCTs assessing CGM were included, with 825 patients in 9 RCTs using rt-CGM and 822 in 5 RCTs using FGM. Moderate certainty of evidence indicated that use of CGM had a modest but statistically significant reduction in HbA1c levels of about 0.32%. Our analyses of each device type separately showed similar reductions in HbA1c (0.34% and 0.33%, respectively, for rt-CGM and FGM), with trends for improvement in other glucose metrics favoring rt-CGM over self-monitored blood glucose. CONCLUSION: Both rt-CGM and flash CGM led to modest but statistically significant declines in HbA1c among individuals with T2DM, with little heterogeneity in the results. However, the duration of the included RCTs was relatively short and few studies reported on important clinical outcomes, such as adverse events, emergency department use, or hospitalization. Longer term studies are needed to determine if the short-term improvements in glucose control leads to improvements in clinically important outcomes.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Uhl S, Choure A, Rouse B, et al. Effectiveness of Continuous Glucose Monitoring on Metrics of Glycemic Control in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Controlled Trials. J Clin Endocrinol Metab. 2024. PMID: 37987208. doi:10.1210/clinem/dgad652

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。